These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36982185)

  • 41. Democratizing FLASH Radiotherapy.
    Moreau M; Mao S; Ngwa U; Yasmin-Karim S; China D; Hooshangnejad H; Sforza D; Ding K; Li H; Rezaee M; Narang AK; Ngwa W
    Semin Radiat Oncol; 2024 Jul; 34(3):344-350. PubMed ID: 38880543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.
    Guckenberger M; Richter A; Wilbert J; Flentje M; Partridge M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e275-82. PubMed ID: 21497450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultra-high dose rate dosimetry: Challenges and opportunities for FLASH radiation therapy.
    Romano F; Bailat C; Jorge PG; Lerch MLF; Darafsheh A
    Med Phys; 2022 Jul; 49(7):4912-4932. PubMed ID: 35404484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Volume effects in the TCP for hypoxic and oxygenated tumors.
    Chvetsov AV; Stewart RD; Kim M; Meyer J; Rengan R
    Med Phys; 2020 Sep; 47(9):4626-4633. PubMed ID: 32452034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
    Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
    Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiobiological Aspects of FLASH Radiotherapy.
    Hageman E; Che PP; Dahele M; Slotman BJ; Sminia P
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
    Stavreva NA; Warkentin B; Stavrev PV; Fallone BG
    Med Phys; 2005 Mar; 32(3):720-5. PubMed ID: 15839343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On cold spots in tumor subvolumes.
    Tomé WA; Fowler JF
    Med Phys; 2002 Jul; 29(7):1590-8. PubMed ID: 12148742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of generalized time-dependent TCP model and the investigation of the effect of repopulation and weekend breaks in fractionated external beam therapy.
    Lee TK; Rosen II
    J Theor Biol; 2021 Mar; 512():110565. PubMed ID: 33346019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
    Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
    Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy and toxicity of FLASH radiotherapy: A systematic review.
    Omyan G; Musa AE; Shabeeb D; Akbardoost N; Gholami S
    J Cancer Res Ther; 2020; 16(6):1203-1209. PubMed ID: 33342774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Computer Modeling Study of Water Radiolysis at High Dose Rates. Relevance to FLASH Radiotherapy.
    Alanazi A; Meesungnoen J; Jay-Gerin JP
    Radiat Res; 2021 Feb; 195(2):149-162. PubMed ID: 33300999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor Control Probability Modeling for Radiation Therapy of Keratinocyte Carcinoma.
    Prior P; Awan MJ; Wilson JF; Li XA
    Front Oncol; 2021; 11():621641. PubMed ID: 34079752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of heterogeneous target dose and radiosensitivity on BED and TCP for different treatment regimens.
    Kuperman VY; Lubich LM
    Phys Med Biol; 2021 Jul; 66(15):. PubMed ID: 33910174
    [No Abstract]   [Full Text] [Related]  

  • 56. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
    King CR; DiPetrillo TA; Wazer DE
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comment on 'viability of the EUD and TCP concepts as reliable dose indicators'.
    Vaarkamp J; Zhu Y
    Phys Med Biol; 2000 Jul; 45(7):L11-6. PubMed ID: 10943940
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
    Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
    Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability.
    Fakir H; Hlatky L; Li H; Sachs R
    Med Phys; 2013 Dec; 40(12):121716. PubMed ID: 24320502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.